BNP Paribas Financial Markets
BLCM

BNP Paribas Financial Markets’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

BNP Paribas Financial Markets’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-16
Closed -$204 – 4517
2019
Q4 		$204 Sell
16
-442
-97% -$4.08K ﹤0.01% 4307
2019
Q3 		$4.81K Hold
458
– – ﹤0.01% 4276
2019
Q2 		$7.79K Sell
458
-799
-64% -$21.6K ﹤0.01% 4157
2019
Q1 		$42.4K Buy
1,257
+555
+79% +$18.6K ﹤0.01% 3599
2018
Q4 		$20.5K Sell
702
-993
-59% -$44.1K ﹤0.01% 3107
2018
Q3 		$104K Hold
1,695
– – ﹤0.01% 2717
2018
Q2 		$125K Buy
1,695
+1,047
+162% +$81.6K ﹤0.01% 2672
2018
Q1 		$42.5K Buy
648
+27
+4% +$2.04K ﹤0.01% 3643
2017
Q4 		$52.2K Buy
621
+358
+136% +$35.1K ﹤0.01% 3644
2017
Q3 		$30.4K Hold
263
– – ﹤0.01% 3391
2017
Q2 		$30.7K Buy
263
+262
+26,200% +$32.5K ﹤0.01% 3433
2017
Q1 		$123 Sell
1
-34
-97% -$4.45K ﹤0.01% 3993
2016
Q4 		$4.81K Sell
35
-110
-76% -$19.5K ﹤0.01% 3724
2016
Q3 		$28.9K Buy
145
+60
+71% +$10.3K ﹤0.01% 2694
2016
Q2 		$11K Buy
+85
New +$9.46K ﹤0.01% 2870
2016
Q1 		– Sell
-165
Closed -$33.4K – 3182
2015
Q4 		$33.4K Sell
165
-22
-12% -$3.94K ﹤0.01% 3069
2015
Q3 		$27.2K Buy
187
+118
+171% +$21.7K ﹤0.01% 3205
2015
Q2 		$14.6K Buy
69
+49
+245% +$12K ﹤0.01% 3225
2015
Q1 		$4.63K Buy
+20
New +$4.84K ﹤0.01% 3201

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets's BLCM Position: Q1 2020 in Review

BNP Paribas Financial Markets sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q1 2020, closing a stake of 16 shares — an estimated $204 sold.

BNP Paribas Financial Markets first reported a position in BLCM in Q1 2015 and held it in 19 quarters. The position peaked at $125K in Q2 2018. 29 funds tracked by Wall St. Rank hold BLCM as of Q1 2020.

  • BNP Paribas Financial Markets reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 16 Bellicum Pharmaceuticals, Inc. shares in Q1 2020, an estimated $204.
  • BNP Paribas Financial Markets first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2015 and held it in 19 quarters.
  • BNP Paribas Financial Markets's Bellicum Pharmaceuticals, Inc. position peaked at $125K in Q2 2018.
  • 29 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q1 2020.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2020, filed 13 May 2020.